MCF Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

MCF Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.02K	Hold	100	–	–	﹤0.01%	1273
2026 Q1	$1.96K	Buy	+100	New	+$2.45K	﹤0.01%	1202

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

MCF Advisors's AMPH Position: Q2 2026 in Review

MCF Advisors held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 100 shares worth $2.02K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

MCF Advisors first reported a position in AMPH in Q1 2026 and has held it in 2 quarters since. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

MCF Advisors held 100 shares of Amphastar Pharmaceuticals worth $2.02K as of Q2 2026.
MCF Advisors left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
Amphastar Pharmaceuticals made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #1273 holding.
MCF Advisors first reported a position in Amphastar Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.